A lower threshold for T2-FLAIR mismatch is in line with a more recently described feature, named “fluid attenuation in non-contrast-enhancing tumor,” which has been shown to predict IDH mutations in glioblastoma [21]. Here, IDH2 is linked to neoplasm.